BOBBY W PHD SANDAGE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BOBBY W PHD SANDAGE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BOBBY W PHD SANDAGE. BOBBY W PHD SANDAGE is Executive Vice President in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in MATEON THERAPEUTICS INC ($OXGN).
Latest Insider Trading Transactions of BOBBY W PHD SANDAGE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | SANDAGE BOBBY W. JR., PHD. | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
| Jun 12 2017 | OXGN | MATEON THERAPEUTIC ... | SANDAGE BOBBY W. JR., PHD. | Director | Option Exercise | A | 0.51 | 121,483 | 61,956 | 121,483 | |
| Oct 27 2016 | OXGN | MATEON THERAPEUTIC ... | SANDAGE BOBBY W PHD | Director | Option Exercise | A | 0.58 | 135,612 | 78,655 | 135,612 | |
| Jan 27 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 2.38 | 3,000 | 7,140 | 434,500 | |
| Jan 27 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Gift | G | 0.00 | 3,000 | 0 | 60,313 | 63.3 K to 60.3 K (-4.74 %) |
| Jan 27 2006 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Buy | M | 2.38 | 3,000 | 7,140 | 63,313 | 60.3 K to 63.3 K (+4.97 %) |
| Oct 04 2005 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 2.37 | 2,274 | 5,389 | 60,313 | 58 K to 60.3 K (+3.92 %) |
| Mar 11 2005 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 3.70 | 25,000 | 92,500 | 25,000 | |
| Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 2.38 | 15,000 | 35,625 | 437,500 | |
| Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 2.38 | 10,000 | 23,750 | 452,500 | |
| Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | S | 7.13 | 15,000 | 106,950 | 58,039 | 73 K to 58 K (-20.54 %) |
| Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 2.38 | 15,000 | 35,625 | 73,039 | 58 K to 73 K (+25.84 %) |
| Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | S | 7.13 | 10,000 | 71,300 | 58,039 | 68 K to 58 K (-14.70 %) |
| Oct 04 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Grant | A | 2.38 | 10,000 | 23,750 | 68,039 | 58 K to 68 K (+17.23 %) |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 6.19 | 500,000 | 3,095,000 | 500,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 6.19 | 500,000 | 3,095,000 | 0 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 4.16 | 100,000 | 416,000 | 100,000 | |
| Sep 16 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | D | 4.16 | 100,000 | 416,000 | 0 | |
| Aug 23 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | M | 2.38 | 10,000 | 23,800 | 32,105 | |
| Aug 23 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Gift | G | 6.85 | 10,000 | 68,500 | 58,039 | 68 K to 58 K (-14.70 %) |
| Aug 23 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Buy | M | 2.38 | 10,000 | 23,800 | 68,039 | 58 K to 68 K (+17.23 %) |
| Jun 09 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | S | 7.59 | 12,500 | 94,875 | 58,039 | 70.5 K to 58 K (-17.72 %) |
| Jun 07 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Sell | S | 7.75 | 7,500 | 58,125 | 70,539 | 78 K to 70.5 K (-9.61 %) |
| Apr 01 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Buy | M | 2.13 | 1,711 | 3,644 | 78,585 | 76.9 K to 78.6 K (+2.23 %) |
| Mar 12 2004 | IDEV | Endo Pharmaceutica ... | SANDAGE BOBBY W PHD | Executive Vice Pres ... | Option Exercise | A | 5.92 | 60,000 | 355,200 | 60,000 |
Page: 1